Ovarian Cancer

CLINICAL_TRIALS trial_result · 2026-03-10

Clinical Trial Update: Apatinib and Etoposide in Patients With Platinum Resistant or Refractory Ovarian Cancer [Phase 2]

Phase 2 trial evaluating the combination of apatinib and etoposide in platinum-resistant or refractory ovarian cancer has completed.

CLINICAL_TRIALS trial_result · 2026-03-10

Clinical Trial Update: Pamiparib Plus Surufatinib in Patients With Platinum-resistant Ovarian Cancer [Phase 1, Phase 2]

This is a clinical trial update on a Phase 1/2 study evaluating pamiparib plus surufatinib for platinum-resistant ovarian cancer and related…

CLINICAL_TRIALS research · 2026-03-10

Clinical Trial Update: The PROOV Study: Exploiting the Synergistic Effect of PARP Inhibition With Cisplatin and Hyperthermia During Interval Cytoreductive Surgery and HIPEC in Ovarian Cancer [Phase 1, Phase 2]

Phase 1/2 clinical trial evaluating a PARP inhibitor in combination with cisplatin and hyperthermia during interval cytoreductive surgery an…

CLINICAL_TRIALS research · 2026-03-10

Clinical Trial Update: Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT [Phase 1, Phase 2]

Phase 1/2 clinical trial update evaluating N-acetylcysteine (NAC) to prevent chemotherapy-related cognitive impairment in ovarian cancer pat…

CLINICAL_TRIALS research · 2026-03-10

Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors [Phase 2]

The document provides an update on a Phase 2 clinical trial sponsored by Hoffmann-La Roche evaluating biomarker-driven therapies for persist…

CLINICAL_TRIALS trial_result · 2026-03-09

Clinical Trial Update: Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65). [Phase 3]

Phase 3 trial assessing pembrolizumab with paclitaxel, with or without bevacizumab, for platinum-resistant recurrent ovarian cancer; results…

CLINICAL_TRIALS research · 2026-03-09

Clinical Trial Update: Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention [NA]

The study IGNITE-TX is a feasibility trial from MD Anderson Cancer Center to identify individuals for genetic testing and treatment across m…

CLINICAL_TRIALS trial_result · 2026-03-09

Clinical Trial Update: Trial of NP-G2-044 (Prilukae) Combined With PLD for Treatment of Platinum-Resistant Ovarian Cancer (ULTIMUS-1) [Phase 2, Phase 3]

A Phase 2/Phase 3 trial (ULTIMUS-1) evaluating NP-G2-044 (Prilukae) with PLD for platinum-resistant ovarian cancer is active but not recruit…

CLINICAL_TRIALS research · 2026-03-09

Clinical Trial Update: Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members [NA]

Clinical trial evaluating energy balance interventions to increase physical activity in BRCA mutation carriers, Lynch syndrome patients, CLL…

CLINICAL_TRIALS trial_result · 2026-03-09

Clinical Trial Update: Michigan Genetic Hereditary Testing (MiGHT) [NA]

The MiGHT hereditary genetic testing trial at the University of Michigan Rogel Cancer Center has completed, evaluating testing across multip…

CLINICAL_TRIALS research · 2026-03-09

Clinical Trial Update: Depression Treatment and Screening in Ovarian Cancer Patients [Phase 1]

A Phase 1 clinical trial update investigating depression treatment and screening in patients with ovarian cancer and related cancers; the st…

CLINICAL_TRIALS research · 2026-03-06

Clinical Trial Update: Iparomlimab/Tuvonralimab + Standard Chemotherapy and Olaparib in Platinum-Sensitive Recurrent Ovarian Cancer [Phase 2]

Phase 2 trial of Iparomlimab/Tuvonralimab with standard chemotherapy and Olaparib in platinum-sensitive recurrent ovarian cancer; currently …

CLINICAL_TRIALS trial_result · 2026-03-06

Clinical Trial Update: Choices About Genetic Testing And Learning Your Risk With Smart Technology [NA]

A completed Rutgers-led trial evaluated choices about genetic testing and learning cancer risk using smart technology across multiple cancer…

CLINICAL_TRIALS research · 2026-03-06

Clinical Trial Update: Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology) [NA]

Medtronic MITG reports ongoing recruitment for the Hugo Robotic-Assisted Surgery System in gynecologic indications. The conditions being stu…

CLINICAL_TRIALS research · 2026-03-06

Clinical Trial Update: BRCA Founder OutReach (BFOR) Study

The BRCA Founder OutReach (BFOR) Study sponsored by Memorial Sloan Kettering Cancer Center is currently active but not recruiting.

CLINICAL_TRIALS trial_result · 2026-03-06

Clinical Trial Update: QLS5132 Combination Therapy in Advanced Solid Tumors [Phase 1, Phase 2]

This update describes a Phase 1/2 study of QLS5132 combination therapy in multiple cancers, including gastric cancer, non-small cell lung ca…

CLINICAL_TRIALS research · 2026-03-06

Clinical Trial Update: A Phase Ib/Ⅱ Clinical Trial of LBL-024 Combined With Paclitaxel in Patients With Platinum-resistant Ovarian Cancer [Phase 1, Phase 2]

This clinical trial update describes a Phase Ib/II study evaluating LBL-024 in combination with paclitaxel for platinum-resistant ovarian ca…

CLINICAL_TRIALS research · 2026-03-06

Clinical Trial Update: Using Advanced Imaging Studies to Develop a Profile of High-grade Serous Ovarian Cancer [NA]

This Memorial Sloan Kettering-led trial update describes using advanced imaging to develop an imaging-based profile of high-grade serous ova…